Hyperuricemia is associated with musculoskeletal pain

November 25, 2016

Episodes of diffuse musculo-skeletal pain appearing in and around a joint region without a clear diagnosis, etiology and therapy are still a major problem in general medical practice. Our cross-sectional study addresses the question of whether slightly elevated urate levels are associated with musculo-skeletal pain.

While the usefulness of urate-lowering treatment in patients with clinical manifestations of hyperuricemia has been established, its use in asymptomatic hyperuricemia is still the object of several controversies. Nevertheless evidence rises for uric acid in non-gouty patients to be an independent cardiovascular and metabolic risk factor. Asymptomatic hyperuricemia is both associated with as well as a predictor of hypertension, renal deficiency and diabetes. Therefore, uric acid is increasingly seen as part of the metabolic syndrome.

Since evidence for subclinical musculo-skeletal involvement in otherwise asymptomatic individuals with hyperuricemia is lacking, urate lowering therapy to date is only indicated and reimbursed in cases of confirmed gout. Current international guidelines do not address the pharmacologic management of asymptomatic hyperuricemia due to a paucity of prospective, randomized, controlled intervention trials in that area. Still, there are no data available how many patients with asymptomatic hyperuricemia have to be treated to prevent one patient with gout (number needed to treat/number needed to harm). However, in a cross-sectional controlled study, ultrasound findings demonstrate the signs of present monosodium urate crystal tissue deposition in both intra- and extra-articular structures from asymptomatic hyperuremic individuals.
-end-
For more information, please visit http://benthamopen.com/ABSTRACT/TOPAINJ-9-15

Reference: Comberg, H.; et al (2016). Hyperuricemia is Associated with Musculo-skeletal Pain - Results from a Cross-sectional Study. Open Pain J., DOI: 10.2174/1876386301609010015

Bentham Science Publishers

Related Gout Articles from Brightsurf:

Gout drug repurposed to fight heart disease
Colchicine reduces the risk of major cardiovascular events in patients with chronic coronary disease, according to results of the LoDoCo2 trial presented in a Hot Line session today at ESC Congress 2020.1 ''Over a decade, more than one in three heart patients will have another heart attack or stroke, or die from heart disease, despite taking preventive medication,'' said study author Dr.

Gout treatment may aid patients with congenital heart disease
A drug used to treat gout, probenecid, may improve heart function in individuals with a particular heart defect, according to results from a small pilot study run by a University of Cincinnati researcher.

EULAR: Amputations of body parts: The combination of diabetes and gout significantly increases
Compared to the average population, people suffering from both gout and diabetes have a 25 times higher risk of requiring an amputation of peripheral limbs such as feet, toes or lower legs.

Gout diagnoses rising worldwide
The prevalence of gout -- a form of arthritis characterized by severe pain, redness, and tenderness in joints--increased across the world at an alarming rate from 1990 to 2017, according to an analysis published in Arthritis & Rheumatology.

ACR releases gout management guideline
Today, the American College of Rheumatology (ACR) released the 2020 Guideline for the Management of Gout.

New optical biosensor system may help round-the-clock management of gout
In a recent article published in the February issue of the journal sensors, researchers at Texas A&M University have reported a technology that might help people with gout disease monitor their symptoms better.

Blood pressure drug linked to lower risk of gout
A new study led by physician-researchers at Beth Israel Deaconess Medical Center (BIDMC) reports that the antihypertensive drug amlodipine lowered long-term gout risk compared to two other drugs commonly prescribed to lower blood pressure.

Wearable sweat sensor detects gout-causing compounds
Caltech's Wei Gao has developed an easier way to mass-produce highly sensitive sweat sensors that can detect a variety of low-concentration compounds related to health conditions

WSU study identifies potential new target for treatment of gout
Researchers at Washington State University Health Sciences Spokane and elsewhere have identified a new therapeutic target for the treatment of gout, a common type of arthritis that causes episodes of painful and stiff joints.

Heart, kidney disease risk factors for adverse effects from gout medication
Heart disease is an independent risk factor for severe adverse skin reactions in patients taking allopurinol, found a study published in CMAJ (Canadian Medical Association Journal).

Read More: Gout News and Gout Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.